The mission of the Boston University Alzheimer's Disease Center (BU ADC) is to facilitate and promote high impact research on the etiology, pathogenesis, diagnosis, treatment, and prevention of Alzheimer's disease (AD), Chronic Traumatic Encephalopathy (CTE) and related disorders through the provision of well- characterized participants, brain tissue, biological specimens, and intellectual resources to qualified investigators. The prime directive of the Administrative Core is to deploy the administrative processes required to accomplish this mission. The Core manages and coordinates internal interactions between the ADC Director and Core Leaders, interactions between the BU ADC and investigators at BU and elsewhere, BU administration, staff at NIA, and local and national community organizations. The Administrative Core is under the leadership of BU ADC founder and Director, Dr. Neil Kowall supported by an Executive Committee comprised of BU ADC core leaders and other senior thought leaders at BUMC. An External Advisory Committee, ad hoc Pilot Project Review Committee, Community Action Council, and ad hoc Internal Advisory Committee help Dr. Kowall and the executive committee coordinate, plan, oversee, and evaluate BU ADC activities and ensure the optimal utilization of BU ADC resources. Ongoing, interactive communication and input is solicited from multiple sources, including our local research community, external AD and CTE experts, and NIA, to strengthen and improve performance. The Administrative Core budget supports centralized administrative personnel and activities relevant to promoting the BU ADC mission.
The aims of the BU ADC Administrative Core are: 1) to integrate, coordinate, direct and plan all BU ADC activities and ensure full compliance with human subjects, animal welfare, scientific integrity, and financial policy requirements of NIH while promoting a culture that values and promotes the highest standards of ethics in clinical care and research guided by input from the scientific and lay communities; 2) to foster innovative AD and CTE research by providing visionary leadership and by facilitating cross-core interactions and coordinating the provision of resources including pilot project support to qualified investigators at BU and other local, national, and international research programs; 3) to partner with local, regional, national and international AD and CTE research communities to support high-impact research; and 4) to support and inform the communities we serve regarding the benefits of the BU ADC and AD and CTE research and to solicit feedback and advice from them. We have an active and engaged Community Action Council, a longstanding and strong affiliation with our local Alzheimer's Association, and an new partnership with the Concussion Legacy Foundation, a nonprofit group dedicated to advancing the study, treatment, and prevention of the effects of brain trauma in athletes and other at-risk groups through advocacy, education, policy development, and medical research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG013846-23
Application #
9761399
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
23
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Boston University
Department
Type
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Chung, Jaeyoon; Wang, Xulong; Maruyama, Toru et al. (2018) Genome-wide association study of Alzheimer's disease endophenotypes at prediagnosis stages. Alzheimers Dement 14:623-633
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Farrar, Danielle C; Mian, Asim Z; Budson, Andrew E et al. (2018) Functional brain networks involved in decision-making under certain and uncertain conditions. Neuroradiology 60:61-69
Christensen, Kurt D; Uhlmann, Wendy R; Roberts, J Scott et al. (2018) A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone. Genet Med 20:132-141
Morrison, Filomene G; Miller, Mark W; Wolf, Erika J et al. (2018) Reduced interleukin 1A gene expression in the dorsolateral prefrontal cortex of individuals with PTSD and depression. Neurosci Lett 692:204-209
Nicolas, Aude (see original citation for additional authors) (2018) Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron 97:1268-1283.e6

Showing the most recent 10 out of 791 publications